DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0017668 | Focal glomerulosclerosis | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0349631 | Richter's syndrome | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0029463 | Osteosarcoma | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0011849 | Diabetes Mellitus | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0006849 | Oral candidiasis | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0021053 | Immune System Diseases | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0004096 | Asthma | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0025362 | Mental Retardation | PLCH2 | 9651 | phospholipase C eta 2 | O75038 |
C0036341 | Schizophrenia | PLCH2 | 9651 | phospholipase C eta 2 | O75038 |
C3714756 | Intellectual Disability | PLCH2 | 9651 | phospholipase C eta 2 | O75038 |
C0004509 | Azoospermia | PLCH2 | 9651 | phospholipase C eta 2 | O75038 |
C3554460 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 12 | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C1319315 | Adenocarcinoma of large intestine | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C0007102 | Malignant tumor of colon | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C0242379 | Malignant neoplasm of lung | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C0007131 | Non-Small Cell Lung Carcinoma | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C0684249 | Carcinoma of lung | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C0007137 | Squamous cell carcinoma | PLCH1 | 23007 | phospholipase C eta 1 | Q4KWH8 |
C2239176 | Liver carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0027651 | Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0006826 | Malignant Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0546837 | Malignant neoplasm of esophagus | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0152018 | Esophageal carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C1848296 | DOSAGE-SENSITIVE SEX REVERSAL | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024